Who owns AVALYN PHARMA INC?
- CUSIP Number: 05348y105
Tip: Access positions for across all investors
Analyze quarterly positions in Avalyn Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Avalyn Pharma stock
Who bought or sold AVALYN PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Sr One Capital Management | 3.3M | $109M | 100% | Jun 2026 |
|
| NVP Associates | 2.3M | $75M | 100% | Jun 2026 |
|
| Pivotal bioVenture Partners Investment Advisor | 967k | $32M | 100% | Jun 2026 |
|
| Vanguard Capital Management | 740k | $24M | 100% | Jun 2026 |
|
| Soleus Capital Management | 419k | $14M | 100% | Jun 2026 |
|
| Federated Investors | 160k | $5.3M | 100% | Jun 2026 |
|
| Vanguard Portfolio Management | 117k | $3.9M | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 117k | $3.8M | 100% | Jun 2026 |
|
| TD Asset Management | 95k | $3.1M | 100% | Jun 2026 |
|
| Standard Life Aberdeen | 67k | $2.2M | 100% | Jun 2026 |
|
| Bank of New York Mellon | 40k | $1.3M | 100% | Jun 2026 |
|
| Vanguard Global Advisers | 7.5k | $246k | 100% | Jun 2026 |
|
| Jpmorgan Chase & Co | 7.1k | $220k | 100% | Jun 2026 |
|
| New York State Common Retirement Fund | 6.0k | $198k | 100% | Jun 2026 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 3.4k | $112k | 100% | Jun 2026 |
|
| Russell Investments | 1.4k | $45k | 100% | Jun 2026 |
|
| Tower Research Capital | 1.1k | $35k | 100% | Jun 2026 |
|
| Sterling Capital Management | 149.00 | $4.9k | 100% | Jun 2026 |
|
| Mercer Global Advisors | 116.00 | $3.8k | 100% | Jun 2026 |
|